Prognostic significance of CNNM4 in ovarian cancer: a comprehensive bioinformatics analysis
2024

The Role of CNNM4 in Ovarian Cancer Prognosis

Sample size: 429 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Yiya

Primary Institution: School of Life Sciences, Qilu Normal University, Jinan, China

Hypothesis

CNNM4 expression levels are associated with the prognosis of ovarian cancer.

Conclusion

Elevated CNNM4 expression in ovarian cancer is linked to poor prognosis and may serve as a potential biomarker for diagnosis and treatment.

Supporting Evidence

  • CNNM4 expression was significantly higher in ovarian cancer tissues compared to normal tissues.
  • Higher CNNM4 levels were associated with reduced overall survival in ovarian cancer patients.
  • Statistical analysis showed a significant correlation between CNNM4 expression and clinical features such as age and tumor grade.

Takeaway

This study found that a protein called CNNM4 is found in higher amounts in ovarian cancer cells, which might help doctors predict how patients will do and how to treat them.

Methodology

The study used in vitro experiments, bioinformatics analyses, and data from TCGA and GTEx to assess CNNM4 expression and its impact on ovarian cancer.

Limitations

The study primarily relies on bioinformatics data and may not fully capture the complexity of ovarian cancer biology.

Participant Demographics

The study included data from 429 ovarian cancer patients, primarily women over 40.

Statistical Information

P-Value

0.0054

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fonc.2024.1483425

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication